Ponesimod Patent with Teriflunomide or Leflunomide
Summary
USPTO published Application US20260108501A1 on April 23, 2026, covering a pharmaceutical combination of ponesimod with either teriflunomide or leflunomide. Inventors are Martine Clozel and Laetitia Pouzol, with filing date December 22, 2025, and application number 19429084. The combination is classified under CPC A61P 25/28, indicating neurological therapeutic applications.
“The present invention relates to a pharmaceutical combination comprising a first active ingredient which is ponesimod and a second active ingredient which is selected from the group consisting of teriflunomide and leflunomide.”
About this source
GovPing monitors USPTO Patent Applications - Therapeutics (A61P) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 219 changes logged to date.
What changed
USPTO published a new patent application for a pharmaceutical combination of ponesimod with teriflunomide or leflunomide. The application claims a combination therapy with potential neurological applications under CPC classification A61P 25/28.
Pharmaceutical companies and patent applicants monitoring the MS/treatment pipeline should review this filing for competitive landscape awareness. This publication does not grant patent rights but establishes prior art as of the filing date.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PHARMACEUTICAL COMBINATION COMPRISING PONESIMOD
Application US20260108501A1 Kind: A1 Apr 23, 2026
Inventors
Martine Clozel, Laetitia Pouzol
Abstract
The present invention relates to a pharmaceutical combination comprising a first active ingredient which is ponesimod and a second active ingredient which is selected from the group consisting of teriflunomide and leflunomide.
CPC Classifications
A61K 31/426 A61K 31/167 A61K 31/421 A61P 25/28
Filing Date
2025-12-22
Application No.
19429084
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.